U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H22N2O4
Molecular Weight 378.4211
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AMBRISENTAN, (R)-

SMILES

COC([C@@H](OC1=NC(C)=CC(C)=N1)C(O)=O)(C2=CC=CC=C2)C3=CC=CC=C3

InChI

InChIKey=OUJTZYPIHDYQMC-IBGZPJMESA-N
InChI=1S/C22H22N2O4/c1-15-14-16(2)24-21(23-15)28-19(20(25)26)22(27-3,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-14,19H,1-3H3,(H,25,26)/t19-/m0/s1

HIDE SMILES / InChI
(R)-Ambrisentan is R-isomer impurity of a nonpeptide endothelin ETA receptor antagonist Ambrisentan.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Enantioseparation and impurity determination of ambrisentan using cyclodextrin-modified micellar electrokinetic chromatography: Visualizing the design space within quality by design framework.
2016 Oct 7
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Name Type Language
AMBRISENTAN, (R)-
Common Name English
(R)-AMBRISENTAN
Common Name English
AMBRISENTAN, (-)-
Common Name English
Code System Code Type Description
PUBCHEM
7045769
Created by admin on Sat Dec 16 10:00:30 GMT 2023 , Edited by admin on Sat Dec 16 10:00:30 GMT 2023
PRIMARY
CAS
1007358-76-0
Created by admin on Sat Dec 16 10:00:30 GMT 2023 , Edited by admin on Sat Dec 16 10:00:30 GMT 2023
PRIMARY
FDA UNII
Q1BX7HE63A
Created by admin on Sat Dec 16 10:00:30 GMT 2023 , Edited by admin on Sat Dec 16 10:00:30 GMT 2023
PRIMARY